Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 16.

Meyer, M R; Haas, E; Prossnitz, E R; Barton, M (2009). Non-genomic regulation of vascular cell function and growth by estrogen. Molecular and Cellular Endocrinology, 308(1-2):9-16.

Barton, M; Meyer, M R (2009). Postmenopausal hypertension: mechanisms and therapy. Hypertension, 54(1):11- 18.

Haas, E; Bhattacharya, I; Brailoiu, E; Damjanović, M; Brailoiu, G C; Gao, X; Mueller-Guerre, L; Marjon, N A; Gut, A; Minotti, R; Meyer, M R; Amann, K; Barton, M (2009). Regulatory role of G protein-coupled estrogen receptor for vascular function and obesity. Circulation Research, 104(3):288-291.

Meyer, M R; Barton, M (2009). ERα, ERβ, and gpER: novel aspects of oestrogen receptor signalling in atherosclerosis. Cardiovascular Research, 83(4):605-610.

Barton, M; Haas, E; Bhattacharya, I (2009). Getting radical about obesity: new links between fat and heart disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 29(4):447-448.

Barton, M (2008). Reversal of proteinuric renal disease and the emerging role of endothelin. Nature Clinical Practice Nephrology, 4:490-501.

Barton, M; Yanagisawa, M (2008). Endothelin: 20 years from discovery to therapy. Canadian Journal of Physiology and Pharmacology, 86(8):485-498.

Damjanovic, M; Barton, M (2008). Fat intake and cardiovascular response. Current Hypertension Reports, 10(1):25-31.

Bhattacharya, I; Mundy, A L; Widmer, C C; Kretz, M; Barton, M (2008). Regional heterogeneity of functional changes in conduit arteries after high-fat diet. Obesity, 16(4):743-748.

Meyer, M R; Haas, E; Barton, M (2008). Need for research on estrogen receptor function: importance for postmenopausal hormone therapy and atherosclerosis. Gender Medicine, 5(Suppl):S19-S33.

Mundy, A L; Haas, E; Bhattacharya, I; Widmer, C C; Kretz, M; Baumann, K; Barton, M (2007). Endothelin stimulates vascular hydroxyl radical formation: Effect of obesity. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology, 293(6):R2218-R2224.

Traupe, T; Keller, M; Fojtu, E; Bhattacharya, I; Lang, M; Ha, H R; Jochum, W; Mundy, A L; Barton, M (2007). Antioxidant activity and sex differences of acute vascular effects of amiodarone in advanced atherosclerosis. Journal of Cardiovascular Pharmacology, 50(5):578-584.

Mundy, A L; Haas, E; Bhattacharya, I; Widmer, C C; Kretz, M; Hofmann-Lehmann, R; Minotti, R; Barton, M (2007). Fat intake modifies vascular responsiveness and receptor expression of vasoconstrictors: implications for diet-induced obesity. Cardiovascular Research, 73(2):368-375.

Traupe, T; Nett, P C; Frank, B; Tornillo, L; Hofmann-Lehmann, R; Terracciano, L M; Barton, M (2007). Impaired vascular function in normoglycemic mice prone to autoimmune diabetes: role of nitric oxide. European Journal of Pharmacology, 557(2-3):161-167.

Nett, P C; Teixeira, M M; Candinas, D; Barton, M (2006). Recent developments on endothelin antagonists as immunomodulatory drugs - from infection to transplantation medicine. Recent Patents on Cardiovascular Drug Discovery, 1(3):265-276.

Barton, M (2002). Endothelin receptor blockade and nitric oxide bioactivity [Cardiovascular Research 2001;49:146–151]. Cardiovascular Research, 52(1):161-163.

This list was generated on Mon Sep 24 07:45:52 2018 CEST.